Peregrine Pharmaceuticals (PPHM) Q3 2014 Results Results - Earnings Call Webcast

Peregrine Pharmaceuticals Inc. (PPHM): FQ3 EPS of -$0.06 in-line. Revenue of $3.88M (-44.9% Y/Y) misses by $1.21M.

The following audio is from a conference call that will begin on March 07, 2014 at 11:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.